Azacitidine betapharm 25 mg / mL powder for suspension for injection

Licence status
Authorised: 24/03/2020
Active substances
Azacitidine
Dosage Form
Powder for suspension for injection
Licence number
EU/1/19/1416/001
Licence holder
Betapharm Arzneimittel GmbH

Product documents

Licence information

ATC code
L01BC07 azacitidine
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
24/03/2020